Evaluation of Solubility, Physicochemical Properties, and Cytotoxicity of Naproxen-Based Ionic Liquids

Potentials of ionic liquids to overcome physical and biological barriers

Over the last decades, ionic liquids (IL) have shown great potential in non-invasive delivery starting from synthetic small molecules to biological large molecules. ILs are emerging as a particular class of drug delivery systems due to their unique physiochemical properties, simple surface modification, and functionalization. These features of IL help achieve specific design principles that are essential for a non-invasive drug delivery system. In this review, we have discussed IL and their applications in non-invasive drug delivery systems. We evaluated state-of-the-art development and advances of IL aiming to mitigate the biological and physical barriers to improve transdermal and oral delivery, summarized in this review. We also provided an overview of the various factors determining the systemic transportation of IL-based formulation. Additionally, we have emphasized how the ILs facilitate the transportation of therapeutic molecules by overcoming biological barriers.

Important role of pore-filling mechanism in separating naproxen from water by micro-mesoporous carbonaceous material

Commercial micro-mesoporous carbonaceous material (MCM; 56.8% mesopores) was applied for investigating the removal phenomenon of naproxen drug in aqueous solutions through batch adsorption experiments. Results demonstrated that the adsorption capacity of MCM to naproxen was slightly affected by different pHeq (2.0-11) and ionic strength (0-1 M NaCl). Adsorption kinetics, isotherms, thermodynamics, and mechanisms were evaluated at pH 7.0. Adsorption kinetics indicated the rate constants for adsorption (0.2 × 10-3  L/(mg × min) and desorption (0.076/min) and the adsorption equilibrium constant (2.6 × 10-3  L/mg). Adsorption isotherm showed that MCM exhibited a high-affinity adsorption capacity to naproxen (even at low concentrations) and its Langmuir maximum adsorption capacity (Qmax ) was 252.7 mg/g at 25°C. Adsorption thermodynamics proved that the adsorption process was endothermic and physisorption (ΔH° = 9.66 kJ/mol). The analysis result of pore size distribution demonstrated that the internal pore structure of MCM was appropriate for adsorbing naproxen molecules. Pore-filing mechanism (pore diffusion phenomenon) was confirmed by a considerable decrease in BET-surface area (585 m2 /g) and total pore volume (0.417 cm3 /g) of MCM after adsorbing naproxen (~1000 mg/L and pH 7.0) at 5 min (341 and 0.256), 60 min (191 and 0.205), 120 min (183 and 0.193), 360 min (144 and 0.175), and 24 h (71.6 m2 /g and 0.123 cm3 /g, respectively). The pore diffusion occurred rapidly (even at the initial adsorption period of 5 min). The FTIR technique was applied to identify the existence of C-H···π and n-π interaction. π-π interaction (evaluated through ID /IG ratio and C=C band) played a minor contribution in adsorption mechanisms. The ID /IG ratio (determined by the Raman technique) of MCM before adsorption (1.195) was similar to that after adsorption (1.190), and the wavenumber (C=C band; its FTIR spectrum) slightly shifted from 1638 to 1634 cm-1 after adsorption. A decrease in the Qmax value of MCM from 249 to 217 (H2 O2 -oxidized MCM) or to 224 mg/g (HNO3 -oxidized MCM) confirmed the presence of π-π interaction. Electrostatic attraction was a minor contribution. MCM can serve as a promising material for removing naproxen from water environment through a pore-filling mechanism. PRACTITIONER POINTS: Pore-filling mechanism was proposed by comparing textural properties of MCM before and after adsorbing naproxen. C-H···π and n-π interactions were identified via FTIR technique. π-π interaction was observed by FTIR and Raman techniques. Oxidation of MCM with HNO3 or H2 O2 was a helpful method to explore π-π interaction. Electrostatic attraction was explained through studies: effects of pH and NaCl along with desorption.

Ionic Liquids: New Forms of Active Pharmaceutical Ingredients with Unique, Tunable Properties

This Review aims to summarize advances over the last 15 years in the development of active pharmaceutical ingredient ionic liquids (API-ILs), which make up a prospective game-changing strategy to overcome multiple problems with conventional solid-state drugs, for example, polymorphism. A critical part of the present Review is the collection of API-ILs and deep eutectic solvents (DESs) prepared to date. The Review covers rules for rational design of API-ILs and tools for API-IL formation, syntheses, and characterization. Nomenclature and ionic speciation, and the confusion that these may cause, are highlighted, particularly for speciation in both ILs and DESs of intermediate ionicity. We also highlight in vivo and in vitro pharmaceutical activity studies, with differences in pharmacokinetic/pharmacodynamic depending on ionicity of API-ILs. A brief overview is provided for the ILs used to deliver drugs, and the Review concludes with key prospects and roadblocks in translating API-ILs into pharmaceutical manufacturing.